Analysts think AORT stock price could increase by 6%
Jul 05, 2025, 11:25 AM
0.75%
What does AORT do
Artivion, based in Kennesaw, Georgia, develops solutions for aortic diseases, employing 1,500 staff and offering medical devices like stent grafts and surgical sealants, along with preservation services for human tissues. Their product families include aortic stent grafts, On-X mechanical heart valves, and BioGlue Surgical Adhesive.
9 analysts think AORT stock price will increase by 6.25%. The current median analyst target is $32.64 compared to a current stock price of $30.72. The lowest analysts target is $30.30 and the highest analyst target is $36.75.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
